劉澤星醫生 - 風濕病科
風濕病科專科醫生
重點資料
- 醫務委員會註冊已驗證
- 1 個診所地點黃竹坑
- 風濕病科專科醫生鄧迪大學內外全科醫學士 · 英國皇家內科醫學院院士 · 香港內科醫學院院士 · 1985 年醫科畢業
- 保險計劃資料整理中｜查看詳情
關於醫生
劉澤星醫生是黃竹坑的風濕病科醫生。
學歷
風濕病科專科醫生
- 鄧迪大學內外全科醫學士1985
- 英國皇家內科醫學院院士1988
- 香港醫學專科學院院士（內科）
- 英國愛丁堡皇家內科醫學院院士
地點
保險計劃
常見問題
劉澤星醫生好嗎？
劉澤星醫生是黃竹坑的風濕病科醫生。資歷及註冊資料來自香港醫務委員會。ok.med 不評分，也不排名。
劉澤星醫生是做什麼的？
劉澤星醫生是風濕病科醫生。
劉澤星醫生在哪裡看診？
劉澤星醫生於港怡醫院應診。
研究及論文
共 152 篇，顯示最近 12 篇
按論文主題篩選
主題由同一批 PubMed 論文的醫學分類整理，不代表醫生提供相關診治服務。
- A prospective multicenter randomized controlled trial pre-emptive increase in immunosuppression for asymptomatic serological reactivation in patients with lupus nephritis in clinical remission.Kidney international · 2026
- Association of Reduction in Continuity of Care During COVID-19 Pandemic With Cardiovascular Diseases, Kidney Failure and All-Cause Mortality for People With Diabetes: A Cohort Study in Hong Kong.Diabetes, obesity & metabolism · 2026
- Treatment patterns, treat-to-target goals and clinical outcomes of patients with active lupus nephritis: real-world evidence from a multicentre cohort study.Arthritis research & therapy · 2026
- Serum type I interferon promotes AIM2 inflammasome dysregulation in lupus patients through STAT1 and STAT2.Rheumatology (Oxford, England) · 2026
- Two-year prognosis of mRNA vaccine-related myocarditis compared with historical conventional myocarditis: a population-based cohort study.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2026
- Predictors of damage accrual by organ domain in systemic lupus erythematosus.Rheumatology (Oxford, England) · 2026
- Indirect effect of the COVID-19 pandemic on mortality, complications, and healthcare utilization among people with Chronic Kidney Disease in Hong Kong: an interrupted time series analysis.Journal of nephrology · 2026
- Longitudinal comparison of treat-to-target states and clinical outcomes in patients with late-onset versus early-onset systemic lupus erythematosus.The Journal of rheumatology · 2026
- Infection risk in rheumatoid arthritis patients treated with biologic and targeted synthetic DMARDs: Prediction models and use of machine learning.Joint bone spine · 2026
- Systematic evaluation of long-read and short-read sequencing in neurological disorders diagnosis: a direct comparison study of 310 patients.NPJ genomic medicine · 2026
- Safety of Biologic and Targeted Synthetic Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis: A Longitudinal Analysis.Drug safety · 2026
- Modeling Hereditary Angioedema With Personalized Expanded Potential Stem Cell-Derived Hepatocytes: A CRISPR-Validated Platform for Mutation-Specific Mechanisms and Therapeutic Innovation.Allergy · 2026
論文資料來自 PubMed／Europe PMC，按姓名及機構自動配對；每項均可按連結核對。
網上資料
以上連結按醫生姓名自動配對，未經醫生本人確認。香港同名者不少，請按連結自行核對。
僅供參考，不構成醫療建議。 閱讀完整免責聲明